Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT.

PURPOSE To evaluate the feasibility of using contrast material-enhanced computed tomographic (CT) measurements of hepatic fractional extracellular space (fECS) and macromolecular contrast material (MMCM) uptake to measure severity of liver fibrosis. MATERIALS AND METHODS All procedures were approved by and executed in accordance with University of California, San Francisco, institutional animal care and use committee regulations. Twenty-one rats that received intragastric CCl(4) for 0-12 weeks were imaged with respiratory-gated micro-CT by using both a conventional contrast material and a novel iodinated MMCM. Histopathologic hepatic fibrosis was graded qualitatively by using the Ishak fibrosis score and quantitatively by using morphometry of the fibrosis area. Hepatic fECS and MMCM uptake were calculated for each examination and correlated with histopathologic findings by using uni- and multivariate linear regressions. RESULTS Ishak fibrosis scores ranged from a baseline of 0 in untreated animals to a maximum of 5. Histopathologic liver fibrosis area increased from 0.46% to 3.5% over the same interval. Strong correlations were seen between conventional contrast-enhanced CT measurements of fECS and both the Ishak fibrosis scores (R(2) = 0.751, P < .001) and the fibrosis area (R(2) = 0.801, P < .001). Strong negative correlations were observed between uptake of MMCM in the liver and Ishak fibrosis scores (R(2) = 0.827, P < .001), as well as between uptake of MMCM in the liver and fibrosis area (R(2) = 0.643, P = .001). Multivariate linear regression analysis showed a trend toward independence for fECS and MMCM uptake in the prediction of Ishak fibrosis scores, with an R(2) value of 0.86 (P = .081 and P = .033, respectively). CONCLUSION Contrast-enhanced CT measurements of fECS and MMCM uptake are individually capable of being used to estimate the degree of early hepatic fibrosis in a rat model. SUPPLEMENTAL MATERIAL http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12112452/-/DC1.

[1]  J. Dixon,et al.  Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss , 2004, Hepatology.

[2]  N. Hotta,et al.  Noninvasive assessment of liver disease - measurement of hepatic fibrosis using tissue strain imaging. , 2007, Clinical imaging.

[3]  J. Goldin,et al.  Intra-observer variation in the histopathological assessment of chronic viral hepatitis , 1996 .

[4]  C. Sempoux,et al.  Capillarization of the sinusoids in liver fibrosis: Noninvasive assessment with contrast‐enhanced MRI in the rabbit , 2003, Magnetic resonance in medicine.

[5]  William M. Lee,et al.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  M. Rowland,et al.  Estimation of aqueous distributional spaces in the dual perfused rat liver , 2000, The Journal of physiology.

[7]  Geoffrey Dusheiko,et al.  Telaprevir for previously untreated chronic hepatitis C virus infection. , 2011, The New England journal of medicine.

[8]  B. Maharaj,et al.  SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.

[9]  H. Honda,et al.  Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. , 2006, Radiology.

[10]  P. Brissot,et al.  Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases , 2006, Hepatology.

[11]  M. Manns,et al.  Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis , 2007, Annals of Internal Medicine.

[12]  M. Spinello,et al.  Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis , 2005, Digestive Diseases and Sciences.

[13]  J. Villeneuve,et al.  The hepatic microcirculation in the isolated perfused human liver , 1996, Hepatology.

[14]  E. Schiff,et al.  Histological outcome during long-term lamivudine therapy. , 2003, Gastroenterology.

[15]  Mircea Grigorescu,et al.  Noninvasive biochemical markers of liver fibrosis. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[16]  E. Schiff,et al.  The role of laparoscopy in the diagnosis of cirrhosis. , 1996, Gastrointestinal endoscopy.

[17]  A. Zimmermann,et al.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis. , 1988, The Journal of clinical investigation.

[18]  T. Murakami,et al.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease. , 1999, AJR. American journal of roentgenology.

[19]  S. Friedman.  Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[20]  Benjamin M Yeh,et al.  Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. , 2006, Bioconjugate chemistry.

[21]  P. Bedossa,et al.  Observer variation in assessment of liver biopsies of alcoholic patients. , 1988, Alcoholism, clinical and experimental research.

[22]  P. Roderick,et al.  Performance of serum marker panels for liver fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.

[23]  B. Yeh,et al.  In Vivo Monitoring of Angiogenesis Inhibitory Treatment Effects by Dynamic Contrast-Enhanced Computed Tomography in a Xenograft Tumor Model , 2009, Investigative radiology.

[24]  Panagiotis Samaras,et al.  Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. , 2007, AJR. American journal of roentgenology.

[25]  P. Sutton,et al.  Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. , 1969, British journal of experimental pathology.

[26]  Long R. Jiao,et al.  A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis , 2010, Journal of clinical gastroenterology.

[27]  J. Goldin,et al.  Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. , 1996, Journal of hepatology.

[28]  M. Federle,et al.  Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. , 2009, AJR. American journal of roentgenology.

[29]  N. Afdhal,et al.  Evaluation of Liver Fibrosis: A Concise Review , 2004, American Journal of Gastroenterology.

[30]  Claude B Sirlin,et al.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. , 2006, Radiology.

[31]  K. Chatamra,et al.  High yield micronodular cirrhosis in the rat. , 1982, Gastroenterology.

[32]  J. Iredale,et al.  Emerging Therapies for Liver Fibrosis , 2006, Digestive Diseases.

[33]  M. Manns,et al.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa‐2b and ribavirin , 2003, Hepatology.

[34]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[35]  Richard L Ehman,et al.  MR elastography of the liver: preliminary results. , 2006, Radiology.

[36]  J. Reichen.  The Role of the Sinusoidal Endothelium in Liver Function. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[37]  D M Shames,et al.  Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique , 1993, Magnetic resonance in medicine.

[38]  S. Pol,et al.  Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C , 2008, Annals of Internal Medicine.

[39]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.